The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
ESC Council on hypertension position document on the management of hypertensive emergencies
Open accessAbstract
Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Self-citationJauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
Nogueira, R. G., Jadhav, A. P., Haussen, D. C., Bonafe, A., Budzik, R. F., Bhuva, P., Yavagal, D. R., Ribo, M., Cognard, C., Hanel, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706442 · Cited by 5,629
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2018) · Stroke · doi:10.1161/str.0000000000000158 · Cited by 5,446
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Albers, G. W., Marks, M. P., Kemp, S., Christensen, S., Tsai, J. P., Ortega-Gutierrez, S., McTaggart, R. A., Torbey, M. T., Kim-Tenser, M., Leslie-Mazwi, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713973 · Cited by 4,930
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
Jovin, T. G., Chamorro, A., Cobo, E., de Miquel, M. A., Molina, C. A., Rovira, A., San Román, L., Serena, J., Abilleira, S., Ribó, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503780 · Cited by 4,898
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
A Reversible Posterior Leukoencephalopathy Syndrome
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J.-L., & Caplan, L. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340803 · Cited by 3,340
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.015 · Cited by 1,692
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
Anderson, C. S., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214609 · Cited by 1,614
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
Qureshi, A. I., Palesch, Y. Y., Barsan, W. G., Hanley, D. F., Hsu, C. Y., Martin, R. L., Moy, C. S., Silbergleit, R., Steiner, T., Suarez, J. I., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603460 · Cited by 1,124
Sandset, E. C., Bath, P. M., Boysen, G., Jatuzis, D., Kõrv, J., Lüders, S., Murray, G. D., Richter, P. S., Roine, R. O., Terént, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60104-9 · Cited by 541
Vaughan, C. J., & Delanty, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02539-3 · Cited by 508
Hypertensive Urgencies and Emergencies: Prevalence and Clinical Presentation
Zampaglione, B., Pascale, C., Marchisio, M., & Cavallo-Perin, P. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.144 · Cited by 478
Grossman, E. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540160050032 · Cited by 472
Hypertension in Sub-Saharan African Populations
Opie, L. H., & Seedat, Y. K. (2005) · Circulation · doi:10.1161/circulationaha.105.539569 · Cited by 456 · cited 1×
“17 This is further supported by data showing that many patients who present with a hypertensive emergency have not received antihypertensive medication.(17,18)”
BackgroundEdvinsson, L., Owman, C., & Sjo¨berg, N.-O. (1976) · Brain Research · doi:10.1016/0006-8993(76)90356-5 · Cited by 443
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis
Magee, L. A., Cham, C., Waterman, E. J., Ohlsson, A., & von Dadelszen, P. (2003) · BMJ · doi:10.1136/bmj.327.7421.955 · Cited by 442
McCord, J., Jneid, H., Hollander, J. E., de Lemos, J. A., Cercek, B., Hsue, P., Gibler, W. B., Ohman, E. M., Drew, B., Philippides, G., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188950 · Cited by 429
Drugs for treatment of very high blood pressure during pregnancy
Duley, L., Meher, S., & Jones, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub3 · Cited by 423
Mellick, R. S., Mahler, R. F., & Hughes, B. P. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92145-1 · Cited by 390
Effect of Intravenous Nimodipine on Blood Pressure and Outcome After Acute Stroke
Ahmed, N., Näsman, P., & Wahlgren, N. G. (2000) · Stroke · doi:10.1161/01.str.31.6.1250 · Cited by 324
Marik, P. E., & Varon, J. (2007) · Chest · doi:10.1378/chest.06-2490 · Cited by 285
Anderson, C. S., Huang, Y., Arima, H., Heeley, E., Skulina, C., Parsons, M. W., Peng, B., Li, Q., Su, S., Tao, Q. L., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.561795 · Cited by 257
Hypertensive encephalopathy: A clinicopathologic study of 20 cases
Chester, E. M., Agamanolis, D. P., Banker, B. Q., & Victor, M. (1978) · Neurology · doi:10.1212/wnl.28.9.928 · Cited by 213
Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations
Neskovic, A. N., Hagendorff, A., Lancellotti, P., Guarracino, F., Varga, A., Cosyns, B., Flachskampf, F. A., Popescu, B. A., Gargani, L., Zamorano, J. L., et al. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes193 · Cited by 212
Influence of labetalol on cocaine-induced coronary vasoconstriction in humans
Boehrer, J. D., Moliterno, D. J., Willard, J. E., Hillis, L. D., & Lange, R. A. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90212-8 · Cited by 196
Gregorini, L., Marco, J., Kozàkovà, M., Palombo, C., Anguissola, G. B., Marco, I., Bernies, M., Cassagneau, B. G., Distante, A., Bossi, I. M., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.482 · Cited by 196
Drugs for treatment of very high blood pressure during pregnancy
Duley, L., Henderson-Smart, D. J., & Meher, S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub2 · Cited by 185
Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin
Brogan, W. C., Lange, R. A., Kim, A. S., Moliterno, D. J., & Hillis, L. D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90617-i · Cited by 169
Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting
Patel, K. K., Young, L., Howell, E. H., Hu, B., Rutecki, G., Thomas, G., & Rothberg, M. B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1509 · Cited by 166
Deshmukh, A. J., Kumar, G., Kumar, N., Nanchal, R. S., Gobal, F. A., Sakhuja, A., & Mehta, J. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.046 · Cited by 148
Katz, J. N., Gore, J. M., Amin, A. J., Anderson, F. A., Dasta, J. F., Ferguson, J. J., Kleinschmidt, K., Mayer, S. A., Multz, A. S., Peacock, W. F., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.020 · Cited by 147
Pinna, G., Pascale, C., Fornengo, P., Arras, S., Piras, C., Panzarasa, P., Carmosino, G., Franza, O., Semeraro, V., Lenti, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093542 · Cited by 146
Perfil de crise hipertensiva: prevalência e apresentação clínica
Vilela-Martin, J. F., Higashiama, É., García, E. L., Luizon, M. R., & Cipullo, J. P. (2004) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2004001400004 · Cited by 146
Crémer, A., Amraoui, F., Lip, G. Y. H., Morales, E., Rubin, S., Segura, J., van den Born, B. H., & Gosse, P. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.112 · Cited by 140
Self-citationTrends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013
Janke, A. T., McNaughton, C. D., Brody, A., Welch, R. D., & Levy, P. D. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004511 · Cited by 134
Perioperative management of 63 patients with pheochromocytoma
Boutros, A. R., Bravo, E. L., Zanettin, G., & Straffon, R. A. (1990) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.57.7.613 · Cited by 133
Improving Survival of Malignant Hypertension Patients Over 40 Years
Lane, D. A., Lip, G. Y. H., & Beevers, D. G. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.153 · Cited by 129
Self-citationEthnic disparities in the incidence, presentation and complications of malignant hypertension
van den Born, B.-J. H., Koopmans, R. P., Groeneveld, J. O., & van Montfrans, G. A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249710.21146.38 · Cited by 124
Effect of Sodium Nitroprusside on Mortality in Acute Myocardial Infarction
Durrer, J. D., Lie, K. I., van Capelle, F. J. L., & DURRER, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205133061901 · Cited by 118
Lip, G. Y. H., le Beevers, M., & Beevers, G. (1994) · Journal of Hypertension · doi:10.1097/00004872-199411000-00013 · Cited by 116
Self-citationSteingart, R. M., Bakris, G. L., Chen, H. X., Chen, M., Force, T. L., Ivy, S. P., Leier, C. V., Liu, G., Lenihan, D. J., Lindenfeld, J. M., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.10.018 · Cited by 116
Long-term renal survival in malignant hypertension
Gonzalez, R., Morales, E., Segura, J., Ruilope, L. M., & Praga, M. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq143 · Cited by 116
Self-citationGrassi, D. G., O’Flaherty, M., Pellizzari, M., Bendersky, M., Rodriguez, P., Turri, D., Forcada, P. J., Ferdinand, K. C., Kotliar, C., & on behalf of the Group of Investigators of the REHASE Program (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00001.x · Cited by 93
Effects of saline drinking on malignant course of renal hypertension in rats
Möhring, J., Petri, M., Szokol, M., Haack, D., & Möhring, B. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.230.3.849 · Cited by 92
HYPERTENSIVE RESPONSE TO LABETALOL IN PHÆOCHROMOCYTOMA
BRIGGS, R. S. J., Birtwell, A. J., & Pohl, J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90772-9 · Cited by 90
Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review
Perez, M. I., & Musini, V. M. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.25 · Cited by 86
Lack of difference between malignant and accelerated hypertension.
Ahmed, M. E., Walker, J. M., Beevers, D. G., & Beevers, M. (1986) · BMJ · doi:10.1136/bmj.292.6515.235 · Cited by 82
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study
Amraoui, F., Bos, S., Vogt, L., & van den Born, B. H. (2012) · BMC Nephrology · doi:10.1186/1471-2369-13-71 · Cited by 71
Self-citationPolgreen, L. A., Suneja, M., Tang, F., Carter, B. L., & Polgreen, P. M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05241 · Cited by 64
Cowley, A. W., & Lohmeier, T. E. (1979) · Hypertension · doi:10.1161/01.hyp.1.6.549 · Cited by 64
van den Born, B. H., Löwenberg, E. C., van der Hoeven, N. V., de Laat, B., Meijers, J. C. M., Levi, M. M., & van Montfrans, G. A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328345023d · Cited by 63
Amraoui, F., Van Der Hoeven, N. V., Van Valkengoed, I. G. M., Vogt, L., & Van Den Born, B. H. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12243 · Cited by 53
Self-citationGregorini, L., Marco, J., Palombo, C., Kozàkovà, M., Anguissola, G. B., Cassagneau, B. G., Bernies, M., Distante, A., Marco, I., Fajadet, J. C., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00055-2 · Cited by 52
Frishman, W. H., Strom, J. A., Kirschner, M. W., Poland, M. P., Klein, N. A., Halprin, S. L., LeJemtel, T. H., Kram, M. T., & Sonnenblick, E. H. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90359-3 · Cited by 52
Shantsila, A., Shantsila, E., Beevers, D. G., & Lip, G. Y. H. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001446 · Cited by 44
Self-citationImpact of malignant arterial hypertension on the heart
Gosse, P., Coulon, P., PAPAIOANNOU, G. I., Litalien, J., & Lemétayer, P. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283430b12 · Cited by 42
Self-citationClevidipine versus sodium nitroprusside in acute aortic dissection: A retrospective chart review
Ulici, A., Jancik, J. T., Lam, T., Reidt, S. L., Calcaterra, D., & Cole, J. B. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.06.030 · Cited by 25
Value of retinal examination in hypertensive encephalopathy
Amraoui, F., van Montfrans, G. A., & van den Born, B. H. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.82 · Cited by 22
Self-citation
Research works printed but not linked: 22
- van den Born, 2007, The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension, Am J Hypertens, 20, 900, 10.1016/j.amjhyper.2007.02.018 · doi:10.1016/j.amjhyper.2007.02.018
- Martin, 2004, Hypertensive crisis profile. Prevalence and clinical presentation, Arq Bras Cardiol, 83, 131
- Lohmeier, 1979, Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog, Circ Res, 44, 154, 10.1161/01.RES.44.2.154 · doi:10.1161/01.res.44.2.154
- Mohring, 1978, Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension, Circ Res, 42, 17, 10.1161/01.RES.42.1.17 · doi:10.1161/01.res.42.1.17
- McGregor, 1986, Retinal changes in malignant hypertension, Br Med J (Clin Res Ed), 292, 233, 10.1136/bmj.292.6515.233 · doi:10.1136/bmj.292.6515.233
- Lip, 2001, A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension, Am J Hypertens, 14, 823, 10.1016/S0895-7061(01)02045-3 · doi:10.1016/s0895-7061(01)02045-3
- van den Born, 2008, Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension, Hypertension, 51, 862, 10.1161/HYPERTENSIONAHA.107.103127 · doi:10.1161/hypertensionaha.107.103127
- Sforza, 2017, Diagnostic performance of multi-organ ultrasound with pocket-sized device in the management of acute dyspnea, Cardiovasc Ultrasound, 15, 16., 10.1186/s12947-017-0105-8 · doi:10.1186/s12947-017-0105-8
- Ledingham, 1979, Cerebral complications in the treatment of accelerated hypertension, Q J Med, 48, 25, 10.1093/oxfordjournals.qjmed.a067564 · doi:10.1093/oxfordjournals.qjmed.a067564
- Haas, 1983, Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension, Am J Med, 75, 1071, 10.1016/0002-9343(83)90891-4 · doi:10.1016/0002-9343(83)90891-4
- Clifton, 1989, Intravenous nicardipine in severe systemic hypertension, Am J Cardiol, 64, 16H, 10.1016/0002-9149(89)90975-2 · doi:10.1016/0002-9149(89)90975-2
- Hirschl, 1997, Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies, Intensive Care Med, 23, 885, 10.1007/s001340050426 · doi:10.1007/s001340050426
- Wilson, 1983, Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies, Am J Med, 75, 95, 10.1016/0002-9343(83)90141-9 · doi:10.1016/0002-9343(83)90141-9
- Shusterman, 1993, Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function, Am J Med, 95, 161, 10.1016/0002-9343(93)90256-O · doi:10.1016/0002-9343(93)90256-o
- Pollack, 2009, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension, Ann Emerg Med, 53, 329, 10.1016/j.annemergmed.2008.04.025 · DOI
- Immink, 2008, Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension, Hypertension, 52, 236, 10.1161/HYPERTENSIONAHA.108.110395 · doi:10.1161/hypertensionaha.108.110395
- Marx, 1979, Labetalol infusion in acute myocardial infarction with systemic hypertension, Br J Clin Pharmacol, 8, 233S, 10.1111/j.1365-2125.1979.tb04787.x · doi:10.1111/j.1365-2125.1979.tb04787.x
- Chiariello, 1976, Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction, Circulation, 54, 766, 10.1161/01.CIR.54.5.766 · doi:10.1161/01.cir.54.5.766
- Mann, 1978, Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin, Circulation, 57, 732, 10.1161/01.CIR.57.4.732 · doi:10.1161/01.cir.57.4.732
- Schreiber, 1998, The nitura study–effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema, Intensive Care Med, 24, 557, 10.1007/s001340050615 · doi:10.1007/s001340050615
- Sheaves, 1995, The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma, Postgrad Med J, 71, 58, 10.1136/pgmj.71.831.58-a · doi:10.1136/pgmj.71.831.58-a
- Tauzin-Fin, 2004, Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, Br J Anaesth, 92, 512, 10.1093/bja/aeh083 · doi:10.1093/bja/aeh083
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Self-citationMancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
“Target organs include the retina, brain, heart, large arteries, and the kidneys.(127) This situation requires rapid diagnostic workup and immediate BP reduction to avoid progressive organ failure.”
Self-citation
Metadata
- Authors
- van den Born, B.-J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., Mahfoud, F., Amraoui, F., Persu, A., Kahan, T., Agabiti Rosei, E., de Simone, G., Gosse, P., & Williams, B.
- Venue
- European Heart Journal - Cardiovascular Pharmacotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-08-25
- Volume
- 5
- Issue
- 1
- Pages
- 37-46
- ISSN
- 2055-6837 (ISSN-L)
- 2055-6845
- OpenAlex
- W2888027923
- Cited by
- 296
- References
- 63
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.